Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia Sergina(University of California, San Francisco), Mark M. Moasser(University of California, San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute), Jimmy A. Blair, Donghui Wang(University of California, San Francisco), Megan Rausch(University of California, San Francisco), Byron Hann(University of California, San Francisco)
Cited by 991
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k